CSS
ROIV icon

Cubist Systematic Strategies’s Roivant Sciences ROIV Stock Holding History

Cubist Systematic Strategies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14.3M Buy
+943,163
New +$11.7M 0.07% 405
2024
Q2 		– Sell
-11,890
Closed -$125K – 3858
2024
Q1 		$125K Buy
+11,890
New +$128K ﹤0.01% 3214
2023
Q4 		– Sell
-5,078
Closed -$59.3K – 4032
2023
Q3 		$59.3K Sell
5,078
-92,964
-95% -$1.05M ﹤0.01% 3016
2023
Q2 		$988K Buy
98,042
+79,773
+437% +$714K 0.01% 1966
2023
Q1 		$135K Buy
18,269
+7,355
+67% +$60.6K ﹤0.01% 3376
2022
Q4 		$87.2K Buy
+10,914
New +$60.7K ﹤0.01% 3825
2022
Q3 		– Sell
-998
Closed -$4K – 4680
2022
Q2 		$4K Buy
+998
New +$3.96K ﹤0.01% 4305

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Cubist Systematic Strategies's ROIV Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Roivant Sciences (ROIV) in Q3 2025: 943,163 shares worth $14.3M. The stake represents 0.07% of the portfolio and ranks #405 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ROIV as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in ROIV in Q2 2022 and has held it in 7 quarters since. 338 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Cubist Systematic Strategies held 943,163 shares of Roivant Sciences worth $14.3M as of Q3 2025.
  • Roivant Sciences was a new Cubist Systematic Strategies position in Q3 2025.
  • Roivant Sciences made up 0.07% of Cubist Systematic Strategies's portfolio in Q3 2025, its #405 holding.
  • Cubist Systematic Strategies first reported a position in Roivant Sciences in Q2 2022 and has held it in 7 quarters since.
  • 338 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.